Induction of antibodies by Staphylococcus aureus nasal colonization in young children

N J Verkaik1, A Lebon, C P de Vogel

  • 1Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands. n.j.verkaik@erasmusmc.nl

Insights

Understanding Staphylococcus aureus nasal colonization in children is key for new treatments. Higher antibody levels against specific S. aureus proteins like CHIPS, Efb, IsdA, and IsdH were found in colonized children.

Area of Science:

  • Immunology
  • Microbiology
  • Pediatrics

Background:

  • Developing new antistaphylococcal strategies requires understanding Staphylococcus aureus carriage and human immune responses.
  • The primary humoral immune response to S. aureus and its link to nasal colonization in young children were investigated.

Purpose of the Study:

  • To analyze the association between S. aureus-specific antibody levels (IgG, IgA, IgM) and nasal colonization in children.
  • To identify specific staphylococcal proteins involved in the immune response during colonization.

Main Methods:

  • Sera from 57 children (colonized and non-colonized) were collected serially from birth to 24 months.
  • Flow cytometry-based technology was used to measure antibody binding to 19 staphylococcal proteins.

Main Results:

  • Antibody responses varied significantly between individuals.
  • Antistaphylococcal IgA and IgM levels increased, while IgG levels decreased with age.
  • Colonized children showed higher IgG and IgA levels against specific proteins, including chemotaxis inhibitory protein of S. aureus (CHIPS), extracellular fibrinogen-binding protein (Efb), iron-responsive surface determinant H (IsdH), and IsdA.

Conclusions:

  • Placentally transferred maternal IgG did not prevent S. aureus colonization.
  • CHIPS, Efb, IsdA, and IsdH appear to play a role in S. aureus nasal colonization in young children.
  • These findings contribute to developing novel antistaphylococcal strategies.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...